Brian Armstrong’s NewLimit Raises $435M for Human Trials
Crypto News: Bitcoin, Ethereum & XRP News | crypto.news [Unoffi…
June 3, 2026
NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
Discussion in the ATmosphere